Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypic screens for compounds that target the cellular pathologies underlying Parkinson's disease.

Drug discovery today. Technologies - 1 Jan 2013

Tardiff Daniel F, Lindquist Susan

Abstract excerpt

Parkinson's disease (PD) is a devastating neurodegenerative disease that affects over one million patients in the US. Yet, no disease modifying drugs exist, only those that temporarily alleviate symptoms. Because of its poorly defined and highly complex disease etiology, it is essential to embrace unbiased and innovative approaches for identifying new chemical entities that target the underlying toxicities...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Synuclein
Share to Drug Evaluation, Preclinical
Share to High-Throughput Screening Assays

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Parkinson Disease

Share to Phenotype

Share to Yeasts

Source

Open in PubMed Open full text

Identifiers

PMID: 24050240
DOI: 10.1016/j.ddtec.2012.02.003
PMCID: PMC3641658

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotypic screens for compounds that target the cellular pathologies underlying Parkinson's disease.PMID 24050240Read ↗

Phenotypic screens targeting neurodegenerative diseases.Semantic proximity Read ↗

Phenotypic screening strategies for neurodegenerative diseases: a pathway to discover novel drug candidates and potential disease targets or mechanisms.Semantic proximity Read ↗

What causes cell death in Parkinson's disease?Semantic proximity Read ↗

High-content phenotypic screen to identify small molecule enhancers of Parkin-dependent ubiquitination and mitophagy.Semantic proximity Read ↗

High-content phenotypic screen to identify small molecule enhancers of Parkin-dependent ubiquitination and mitophagySemantic proximity Read ↗

Senolytic and senomorphic secondary metabolites as therapeutic agents in Drosophila melanogaster models of Parkinson’s diseaseSemantic proximity Read ↗

Animal models of Parkinson's disease: limits and relevance to neuroprotection studies.Semantic proximity Read ↗

Models of Parkinson's diseaseSemantic proximity Read ↗

Cellular models as tools for the study of the role of alpha-synuclein in Parkinson's disease.Semantic proximity Read ↗

Identifying Therapeutic Agents for Amelioration of Mitochondrial Clearance Disorder in Neurons of Familial Parkinson Disease.Semantic proximity Read ↗

Phenotypic Profiling of Human Stem Cell-Derived Midbrain Dopaminergic Neurons.Semantic proximity Read ↗

The Power of Sophisticated Phenotypic Screening and Modern Mechanism-of-Action Methods.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.